ERF and neoplasm: PE2-treated animals showed an average of 5.5 ± 1.1 tumors per mouse, whereas PE2*-treated mice displayed higher rates of tumor formation, with an average of 10.0 ± 2.7 tumors on the liver (Fig. 4c, d).